Mablink Bioscience raised €31M in a Series A round in Oct 2022. The company is based in Lyon, France. Investors in the round: Crédit Agricole Création, Elaia Partners, Fondation Fournier-Majoie and 5 others. Data as of 7 Aug 2026.
Reported in EUR — no conversion. €31M
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
